Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

Recruiting in Palo Alto (17 mi)

Overseen by Jennifer Kolb, MD, MS

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of Colorado, Denver

No Placebo Group

Trial Summary

What is the purpose of this trial?

This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decrease the number of people who die from esophageal cancer.

Research Team

Sachin Wani, MD

Principal Investigator

University of Colorado, Denver

Jennifer Kolb, MD, MS

Principal Investigator

University of California, Los Angeles

Eligibility Criteria

Inclusion Criteria

I can sign and date the consent form.

I am willing and able to follow all study rules and attend all appointments.

I am over 50, have chronic GERD, am male, white, smoke, am obese, or have a family history of BE/EAC.

Treatment Details

Participant Groups

Group I: Patients Experimental Treatment 1 Intervention

556 eligible patients will be recruited across 5 participating sites to complete a discrete choice-based conjoint survey. The survey will be distributed to eligible patients via Sawtooth internet survey at the time of a clinic appointment or remotely via video chat.

Who Is Running the Clinical Trial?

University of Colorado, Denver

Lead Sponsor

Trials

1,842

Recruited

3,028,000+

Aviva Abosch

University of Colorado, Denver

Chief Medical Officer since 2019

MD

Uday B. Kompella

University of Colorado, Denver

Chief Executive Officer since 2015

PhD in Pharmaceutical Sciences

University of Michigan

Collaborator

Trials

1,891

Recruited

6,458,000+

Marschall S. Runge

University of Michigan

Chief Executive Officer since 2015

MD, PhD

Karen McConnell

University of Michigan

Chief Medical Officer since 2020

MD

Exact Sciences Corporation

Industry Sponsor

Trials

36

Recruited

282,000+

University of California, Los Angeles

Collaborator

Trials

1,594

Recruited

10,430,000+

Dr. Thomas Rando

University of California, Los Angeles

Chief Medical Officer since 2023

MD from UCLA

Amir Naiberg

University of California, Los Angeles

Chief Executive Officer since 2024

JD from UCLA

University of Texas Southwestern Medical Center

Collaborator

Trials

1,102

Recruited

1,077,000+

Daniel K. Podolsky

University of Texas Southwestern Medical Center

Chief Executive Officer since 2008

MD from Harvard Medical School

Robert L. Bass

University of Texas Southwestern Medical Center

Chief Medical Officer since 2019

MD from University of Texas Southwestern Medical School

American Society for Gastrointestinal Endoscopy

Collaborator

Trials

29

Recruited

5,000+

VA Medical Center-West Los Angeles

Collaborator

Trials

5

Recruited

1,600+